Fact-checked by Grok 2 weeks ago

CD63

CD63 is a transmembrane glycoprotein belonging to the tetraspanin superfamily, characterized by four hydrophobic transmembrane domains that facilitate its integration into cellular membranes, and it plays essential roles in protein trafficking, cell signaling, and organelle biogenesis.^[1] As a key component of the endolysosomal system, CD63 localizes primarily to late endosomes, multivesicular bodies, and lysosomes, where it regulates the sorting and transport of cargo proteins, including its interactions with integrins and other membrane partners to mediate signal transduction pathways involved in cell adhesion, migration, activation, and development.^[1] It is ubiquitously expressed across human tissues, with particularly high levels in adipose tissue and colon, and serves as a well-established marker for platelet activation upon degranulation.^[1] Additionally, CD63 is highly enriched on the surface of extracellular vesicles, particularly exosomes, contributing to their formation, release, and intercellular communication by organizing tetraspanin-enriched microdomains that influence processes like pigmentation via endosome-to-melanosome transport and integrin-mediated signaling.^[2]^[3]^[4] In pathological contexts, CD63 exhibits diverse functions, including regulation of viral entry—such as enhancing HIV-1 replication in macrophages through interactions with envelope glycoproteins—and dual roles in cancer, where its overexpression correlates with poor prognosis in colorectal, gastric, and gastrointestinal stromal tumors due to promotion of invasion and metastasis, but with improved survival in lung adenocarcinoma via inhibition of tumor progression.^[5]^[2] Alterations in CD63 localization or deficiency are observed in lysosomal storage disorders like Hermansky-Pudlak syndrome, leading to defects in platelet dense granules, melanosomes, and pulmonary function, though mutations in the CD63 gene itself are not causative.^[6]^[7]

Gene and expression

Genomic organization

The CD63 gene is located on the long arm of human chromosome 12 at the cytogenetic band 12q13.2, specifically at genomic coordinates 55,723,535-55,730,041 on the reverse strand (GRCh38.p14 assembly). It spans approximately 6.5 kb of genomic DNA and comprises 14 exons, which encode the mature mRNA transcripts. This compact genomic organization supports the production of a member of the tetraspanin family, with the gene's structure reflecting evolutionary adaptations for regulated expression in various cellular contexts.^[1] Alternative splicing of the CD63 primary transcript generates multiple mRNA variants, leading to distinct protein isoforms that differ primarily in their N-terminal regions or internal segments rather than extensive C-terminal variations. The canonical isoform A, encoded by transcript variants 1, 3–5, and 10–15, consists of 238 amino acids and includes the full-length sequence. In contrast, isoform C (from variant 7) lacks an internal segment, while isoform D (from variants 8, 9, and 16) features a truncated N-terminus; isoforms E and F arise from variants 14 and 15, respectively, with subtle structural differences. These splicing events contribute to functional diversity without altering the core transmembrane domains. Overall, at least 16 validated transcript variants have been annotated in NCBI, while Ensembl predicts up to 46 including alternative models, highlighting the gene's flexibility in response to cellular signals.^[1]^[8] The CD63 gene demonstrates strong evolutionary conservation among mammals, underscoring its fundamental role in cellular processes. Orthologs are present in diverse species, including the mouse (Cd63 on chromosome 10), rat (Cd63 on chromosome 18), and other primates like rhesus monkey, with high sequence similarity (>85% identity at the protein level in many cases). This conservation extends to non-mammalian vertebrates, such as chicken and zebrafish, indicating ancient origins within the tetraspanin superfamily. Such preservation suggests selective pressure to maintain CD63's involvement in membrane organization across species. Transcriptional regulation of CD63 is governed by elements in the 5'-flanking promoter region, which includes consensus sequences for basal transcription factors and response elements responsive to cellular cues like iron levels via the IRE-IRP system. Early characterization identified promoter activity within approximately 1 kb upstream of the transcription start site, capable of driving expression in diverse cell types, though specific enhancers distal to the core promoter remain less defined in current annotations. These regulatory features ensure context-specific expression, integrating environmental and developmental signals.^[9]

Expression patterns

CD63 is ubiquitously expressed in human tissues, with mRNA and protein levels detectable across nearly all cell types, though quantitative data from transcriptomic analyses indicate varying abundance. According to the Human Protein Atlas, CD63 shows elevated expression in tissues involved in immune function and hormone regulation, such as bone marrow (normalized expression score of approximately 77 in innate immune response contexts) and adrenal gland (score around 26 in steroid metabolism pathways), while lower levels are observed in tissues like liver and kidney.^[10]^[11] At the subcellular level, CD63 protein is primarily localized to intracellular compartments including late endosomes and lysosomes, as well as the plasma membrane, particularly in immune cells. It is highly enriched in platelets, where it resides in dense granules and lysosomal membranes; basophils, on their surface and internal vesicles; and macrophages, within phagolysosomes and endosomal structures. This distribution supports its role in vesicular trafficking, with immunoelectron microscopy confirming CD63's presence in multivesicular endosomes of these cell types.^[12]^[13]^[14] Expression of CD63 is dynamically regulated and upregulated during cellular activation states. In platelets, stimulation by agonists like thrombin leads to rapid translocation and increased surface exposure of CD63 from internal stores, serving as a reliable activation marker. Similarly, in basophils and macrophages, inflammatory stimuli such as allergens or cytokines induce elevated CD63 expression on the cell surface and within activated vesicles, correlating with degranulation and immune response amplification.^[15]90094-5/fulltext)^[16] During development, CD63 exhibits spatiotemporal patterns, notably increasing in maturing melanosomes of melanocytes. In stage III and IV melanosomes, CD63 accumulates on intraluminal vesicles, facilitating protein sorting and organelle maturation essential for pigmentation. This progressive enrichment is observed in both in vitro models and murine melanocytes, highlighting its role in lysosome-related organelle biogenesis.00357-1)^[4]

Protein structure

Topology and domains

CD63 is a 238-amino acid polypeptide encoded by the human CD63 gene, belonging to the tetraspanin superfamily of membrane proteins.^[17] As a typical tetraspanin, it features four hydrophobic transmembrane domains (TM1–TM4) that span the lipid bilayer, with short intracellular N- and C-terminal tails and a brief intracellular loop connecting TM2 and TM3.^[18] These transmembrane segments delineate two extracellular loops: a small extracellular loop (EC1) between TM1 and TM2, and a larger extracellular loop (EC2) between TM3 and TM4, which together form the core topological architecture of the protein.^[19] This configuration positions CD63 predominantly as a lysosome-associated membrane protein (LAMP-3), with its topology adapted for integration into endosomal and lysosomal membranes.^[20] The unglycosylated core protein of CD63 has a calculated molecular weight of approximately 25 kDa, but post-translational N-linked glycosylation at three conserved sites significantly increases its apparent mass to 25–60 kDa, as observed in SDS-PAGE analyses.^[17]^[21] This glycosylation contributes to the protein's heterogeneity and stability within acidic lysosomal environments, while the overall topology remains anchored by the four transmembrane helices that bundle to form a compact intramembrane structure.^[22] Within the EC2 domain, CD63 harbors highly conserved motifs typical of tetraspanins, including the CCG motif (cysteine-cysteine-glycine), where the cysteine residues form intramolecular disulfide bonds essential for stabilizing the loop's folded conformation.^[19] These bonds, along with additional conserved cysteines, create a rigid scaffold that supports the EC2's role in maintaining protein integrity. Homology models of CD63, derived from crystal structures of closely related tetraspanins like CD81, reveal a potential for dimerization, mediated by hydrophobic interactions between transmembrane helices and packing of EC2 domains, which may facilitate higher-order oligomerization in membranes.^[23]

Post-translational modifications

CD63 undergoes N-linked glycosylation at three asparagine residues within its large extracellular loop (EC2): Asn130, Asn150, and Asn172. These modifications, initiated in the endoplasmic reticulum by the oligosaccharyltransferase complex, are critical for proper protein folding, stability, and trafficking. Specifically, glycosylation at Asn172 contributes to CD63's maturation and localization to lysosomes, where it helps prevent proteolytic degradation by shielding the protein from lysosomal enzymes. Inhibition of glycosylation, such as through knockdown of the regulatory subunit RPN2 of the oligosaccharyltransferase, alters CD63 localization from the cell membrane to intracellular compartments and reduces its functional role in endosomal sorting of partner proteins like CXCR4 for lysosomal degradation.^[24]^[25] In addition to glycosylation, CD63 is palmitoylated at cysteine residues in its short intracellular loops adjacent to the transmembrane domains. This reversible thioester linkage, occurring primarily in the Golgi or post-Golgi compartments, enhances CD63's partitioning into detergent-resistant membrane microdomains and strengthens its interactions with other tetraspanins such as CD9, CD81, and CD151. Palmitoylation thereby promotes the assembly and stability of the tetraspanin web, a dynamic network that organizes membrane proteins for adhesion, signaling, and trafficking functions. Mutants lacking these palmitoylation sites exhibit reduced association with partner proteins and altered subcellular distribution, underscoring the modification's role in membrane anchoring.^[26] The cytoplasmic tails of CD63, which are short (N-terminal: residues 1–9; C-terminal: residues 228–238), contain potential phosphorylation sites, including the tyrosine residue (Tyr235) within the C-terminal lysosomal targeting motif GYEVM.^[24] Ubiquitination of CD63 occurs primarily on lysine residues in its cytoplasmic domains and is linked to endocytic trafficking decisions. The E3 ubiquitin ligase RNF149 mediates polyubiquitination at Lys29-linked chains, targeting CD63 for lysosomal degradation and thereby attenuating its surface expression during inflammatory signaling, such as LPS/TLR4 activation. This modification intersects with the ESCRT machinery, where ubiquitinated CD63 is recognized by ESCRT-0 components (e.g., Hrs/STAM) for incorporation into intraluminal vesicles of multivesicular endosomes, facilitating either degradation or selective recycling depending on the ubiquitin chain topology and cellular context. Deubiquitinating enzymes like USP32 counteract ubiquitination to promote endosomal recycling.^[27]^[28]

Biological roles

Cellular signaling and adhesion

CD63 functions as a cell surface receptor for tissue inhibitor of metalloproteinase 1 (TIMP1), facilitating the activation of integrin β1 (ITGB1) signaling cascades that promote cell motility and invasion. Upon TIMP1 binding, CD63 modulates ITGB1 interactions within the membrane, leading to downstream activation of focal adhesion kinase (FAK) and subsequent cytoskeletal rearrangements essential for migratory responses.^[29] This interaction has been demonstrated in various cell types, where disruption of CD63-TIMP1 binding reduces ITGB1-mediated signaling and impairs invasive potential.^[30] As a member of the tetraspanin family, CD63 is recruited to tetraspanin-enriched microdomains (TEMs) at the plasma membrane, where it enhances the clustering of adhesion molecules such as integrins. These TEMs organize lateral associations between CD63 and partners like ITGB1 and CD9, stabilizing adhesion complexes and amplifying signal transduction for cell-cell and cell-matrix interactions. CD63's role in TEMs is critical for efficient adhesion strengthening, as evidenced by studies showing that CD63 knockdown disrupts microdomain integrity and reduces adhesion efficiency in motile cells.^[31]^[32] In platelets, CD63 contributes to activation processes by translocating from intracellular lysosomes to the plasma membrane upon stimulation, triggering aggregation and release reactions. This surface exposure of CD63 coincides with degranulation and co-localization with the αIIbβ3 integrin complex, supporting the propagation of activation signals that lead to thrombus formation.^[33] Palmitoylation of CD63 is essential for its association with these complexes during activation, ensuring coordinated release of granule contents.^[33] CD63-mediated signaling engages downstream pathways such as PI3K/Akt and MAPK, which are activated with distinct kinetics during immune responses, typically peaking within 15-30 minutes post-stimulation in immune cells like macrophages. In the context of TIMP1 engagement, CD63 recruits PI3K to initiate Akt phosphorylation, promoting survival and motility, while MAPK activation drives proliferative responses.^[34] These pathways exhibit rapid onset in response to integrin clustering in TEMs, underscoring CD63's role in fine-tuning immune cell adhesion and activation.^[30]

Vesicle trafficking and exosome biogenesis

CD63 is predominantly localized to the intraluminal vesicles (ILVs) of multivesicular bodies (MVBs) and late endosomes, where it serves as lysosomal-associated membrane protein 3 (LAMP3), reflecting its role in endolysosomal compartments.^[35] In melanocytic cells, approximately 20%–25% of CD63 is found on PMEL-positive MVBs, with over 75% enriched on ILVs, while only 5%–10% appears in lysosomes, underscoring its specific association with maturing endosomal structures rather than degradative lysosomes.^[36] This localization pattern highlights CD63's involvement in the regulated transport within the endocytic pathway, from the trans-Golgi network through early endosomes to late endosomal MVBs.^[37] In exosome biogenesis, CD63 contributes to the formation of ILVs within MVBs through an ESCRT-independent mechanism, distinct from ceramide-dependent pathways, thereby facilitating the generation of extracellular vesicles released upon MVB fusion with the plasma membrane.^[36] It participates in cargo sorting by organizing tetraspanin-enriched microdomains, or "webs," that cluster proteins and lipids for selective packaging into exosomes, including the enrichment of miRNAs and specific proteins such as MHC class II and matrix metalloproteinases.^[38] These webs enable efficient incorporation of cargo into ILVs during inward budding, ensuring targeted release of exosomes that mediate intercellular communication. Additionally, CD63 expression is post-transcriptionally regulated by intracellular iron levels via the IRE-IRP system, influencing extracellular vesicle-mediated iron export.^[39]^[38] As an adaptor in the endocytic machinery, CD63 interacts with clathrin-associated adaptors like AP-2 and AP-3 to regulate the internalization of membrane receptors via clathrin-dependent pathways and their subsequent sorting in recycling endosomes.^[37] This adaptor function modulates receptor trafficking, promoting either lysosomal degradation or recycling to the plasma membrane, and influences the overall dynamics of endosomal maturation.^[38] In specialized contexts, such as pigmentation, CD63 is essential for melanosome biogenesis by directing the ESCRT-independent sorting of PMEL luminal domains into ILVs, where they polymerize into amyloid fibrils necessary for melanosome maturation; defects in CD63 result in reduced ILV formation, impaired fibrillogenesis, and hypopigmentation phenotypes observed in knockout models.^[36]

Clinical significance

Diagnostic applications

CD63 serves as a primary activation marker in the basophil activation test (BAT), a flow cytometry-based assay that quantifies basophil degranulation by measuring CD63 upregulation on the surface of IgE-crosslinked basophils in whole blood samples. This test is widely employed for diagnosing IgE-mediated allergies, including food allergens such as peanut and egg, as well as drug and venom hypersensitivities, offering a safer alternative to in vivo provocation tests by assessing allergen-specific reactivity ex vivo.^[40] The BAT protocol involves stimulating basophils with allergens and detecting CD63 expression, typically defining activation as an increase exceeding the 97.5th percentile of resting basophils, which helps differentiate true allergy from sensitization. Standardized by the European Academy of Allergy and Clinical Immunology (EAACI), these protocols ensure reproducibility across laboratories, with BAT demonstrating high diagnostic accuracy—for instance, sensitivity exceeding 90% and specificity up to 100% for peanut allergy, and sensitivity of 97.6% with 96% specificity for certain drug allergies.^[41]^[42] In platelet function assays, CD63 functions as a reliable marker of dense granule and lysosomal release, becoming exposed on the platelet surface following activation stimuli such as thrombin or ADP, which is detectable via flow cytometry. This application is particularly valuable in evaluating thrombotic disorders, where elevated CD63 expression indicates heightened platelet reactivity and risk of clot formation, as observed in conditions like antiphospholipid syndrome and venous thromboembolism.^[43] For example, in thrombosis risk assessment, CD63 alongside other markers like CD62P helps quantify platelet hyperactivation in patient samples, supporting the diagnosis and monitoring of hemostatic imbalances without invasive procedures.^[44] Studies have shown significantly increased median CD63 expression in patients with primary antiphospholipid syndrome compared to controls, underscoring its utility in clinical hemostasis evaluations.^[43] Emerging diagnostic strategies leverage CD63 as a tetraspanin marker for exosome isolation and quantification in liquid biopsies, particularly from plasma, where CD63-positive extracellular vesicles are captured using affinity-based methods like immunomagnetic beads or ELISA kits to assess disease-associated cargo. This approach facilitates non-invasive detection in oncology and other pathologies, with CD63 enabling high-purity exosome enrichment for downstream analysis of biomarkers such as miRNAs or proteins. Quantification of CD63-expressing exosomes in plasma has shown promise as a prognostic tool, correlating with tumor burden in cancers like esophageal squamous cell carcinoma, though ongoing validation is needed for broader clinical adoption.^[45] Techniques combining CD63 detection with nanoparticle tracking analysis provide sensitive vesicle counts, typically in the range of 10^9 to 10^11 particles per milliliter of plasma, enhancing the precision of liquid biopsy workflows.

Associations with diseases

Mutations in the HPS6 gene cause Hermansky-Pudlak syndrome type 6 (HPS-6), an autosomal recessive disorder characterized by lysosomal storage defects, oculocutaneous albinism, and bleeding diathesis due to impaired biogenesis of lysosome-related organelles, including deficient trafficking and expression of CD63 in platelet dense granules and melanosomes.^[46]^[6] Patients with HPS-6 exhibit early-onset nystagmus, moderate albinism, and mild bleeding tendencies, with CD63 deficiency contributing to platelet secretion defects and prolonged bleeding times.^[47] CD63 exhibits dual roles in cancer, with overexpression associated with poor prognosis in colorectal, gastric, and gastrointestinal stromal tumors due to promotion of invasion and metastasis.^[2] In lung adenocarcinoma, higher CD63 expression generally correlates with improved survival and inhibition of tumor progression, though specific interactions, such as stromal TIMP-1 binding to CD63 on tumor cells, can drive epithelial-mesenchymal transition and metastasis in certain contexts.^[2]^[48] In melanoma, CD63 acts as a tumor suppressor, reducing cell invasion and metastasis.^[2] A 2024 study showed that CD63-positive tumor-associated macrophages induce epithelial-mesenchymal transition and lipid reprogramming to accelerate hepatocellular carcinoma progression, highlighting CD63's roles in tumor microenvironments.^[49] CD63 plays a role in immune-related disorders beyond HPS, including potential involvement in platelet hyperactivation during COVID-19 infection. In HPS subtypes like type 2, CD63 surface expression is altered on cytotoxic T cells, impairing immune function and contributing to neutropenia and recurrent infections.^[50] Post-2023 research has identified elevated CD63 expression on activated platelets in COVID-19 patients and survivors, indicating dense granule degranulation and heightened thrombotic risk, with persistent platelet hyperactivity observed up to one year post-infection.^[51]^[52] As an exosomal marker, CD63 is elevated in circulating extracellular vesicles from prostate and breast cancer patients, serving as a biomarker for tumor detection and monitoring disease progression in serum-based liquid biopsies.^[53]^[54] This aligns with MISEV2018 guidelines, which designate CD63 alongside tetraspanins like CD9 and CD81 as key identifiers for extracellular vesicles, with increased CD63-positive exosomes correlating to advanced prostate cancer stages and breast cancer metastasis.

Molecular interactions

Protein binding partners

CD63, a member of the tetraspanin family, engages in direct extracellular binding with tissue inhibitor of metalloproteinases 1 (TIMP1), a process that modulates extracellular matrix remodeling by inhibiting metalloproteinase activity. This interaction occurs on the cell surface, where TIMP1 binds to the large extracellular loop of CD63, as identified through yeast two-hybrid screening and confirmed by co-immunoprecipitation assays in various cell types, including breast cancer epithelial cells. The binding facilitates TIMP1's role in cell survival and polarization without direct enzymatic inhibition by CD63 itself.^[55]^[56] Intracellularly, CD63 forms associations with β-integrins, such as integrin β1 (ITGB1), within multimolecular complexes that influence cell adhesion and migration. These interactions are stabilized through co-immunoprecipitation in melanoma cells, where CD63 facilitates the colocalization of TIMP1 with β1-integrins, thereby linking extracellular matrix signaling to cytoskeletal dynamics. Additionally, CD63 interacts with other tetraspanins, including CD82 and CD151, to assemble tetraspanin-enriched microdomains on the plasma membrane and endosomal compartments, as demonstrated by proximity ligation assays and co-immunoprecipitation in epithelial and immune cells. These complexes enhance the lateral organization of adhesion molecules, with CD63 acting as a scaffold for ITGB1 recruitment alongside CD82 and CD151.^[29]^[57] CD63 colocalizes with lysosomal-associated membrane proteins (LAMPs), particularly LAMP1 and LAMP2, in endosomal and lysosomal compartments, contributing to membrane trafficking. These associations are observed in endocytic pathways during amelogenesis and in transfected cells, involving shared motifs for adaptor protein recognition, as evidenced by colocalization studies.^[58] Furthermore, CD63 engages with components of the endosomal sorting complexes required for transport (ESCRT), such as HRS, CHMP4B, and VPS4A, primarily in an ESCRT-independent manner for multivesicular body formation and lysosomal delivery. BioID proximity labeling in Epstein-Barr virus-infected cells has mapped these proximity interactions within the CD63 interactome, highlighting CD63's role in ESCRT machinery association to tetraspanin domains for vesicle maturation, as supported by functional knockdown experiments.^[59]^[4]

Involvement in pathways

CD63 participates in the endocytic recycling pathway through associations with Rab GTPases and AP-2 adaptors, facilitating the sorting and trafficking of membrane proteins in the endolysosomal system. Specifically, CD63 interacts with Rab GTPases such as Rab8A and Rab21A, which regulate vesicle-mediated transport and cargo recycling from early endosomes back to the plasma membrane.^[60] These interactions enable CD63 to coordinate the dynamic movement of endosomal compartments, supporting processes like receptor recycling and multivesicular body formation. Additionally, CD63 binds directly to the μ2 subunit of the AP-2 complex via its C-terminal YEVM motif, promoting clathrin-dependent endocytosis at the plasma membrane and influencing post-endocytic sorting decisions toward recycling or lysosomal degradation.^[61] ^[12] This dual association with Rab GTPases and AP-2 ensures efficient endocytic recycling, with disruptions leading to altered vesicular trafficking.^[38] In cancer contexts, CD63 regulates Wnt/β-catenin signaling through interactions within the tumor microenvironment, often involving exosomal components. The TIMP-1/CD63/ITGB1 complex, where CD63 serves as a key receptor, activates downstream AKT signaling that promotes β-catenin stabilization and nuclear translocation, enhancing oncogenic transcription in breast and other cancers.^[62] This regulatory mechanism can facilitate intercellular transfer of signaling effectors via CD63-enriched exosomes, amplifying Wnt pathway activity in recipient cells and contributing to tumor invasion.^[63] CD63 integrates into immune activation cascades by linking FcεRI receptor signaling to degranulation in mast cells, a critical step in allergic responses. Upon IgE-antigen crosslinking of FcεRI, CD63 supports the fusion of secretory granules with the plasma membrane, enabling mediator release such as β-hexosaminidase and TNF-α.^[64] Deficiency in CD63 reduces degranulation efficiency by impairing downstream signaling or membrane dynamics, without affecting basal lysosomal function or alternative activation pathways like PMA/ionomycin.^[64] In vivo, this manifests as attenuated anaphylaxis, highlighting CD63's role in amplifying FcεRI-mediated immune cascades.^[64] CD63 engages in feedback loops that modulate signaling pathways, exemplified by its mediation of ITGB1 activation feeding into the PI3K/AKT axis within tumor microenvironments. In breast cancer, the TIMP-1/CD63/ITGB1 complex—briefly referencing TIMP-1 as a binding partner—triggers PI3K/AKT phosphorylation, creating a positive feedback that sustains cell migration, growth, and chemoresistance.^[63] This loop is fueled by cancer-associated fibroblasts secreting TIMP-1, which binds CD63 to activate ITGB1 and downstream effectors. However, post-2023 studies reveal context-dependent inhibitory roles, where CD63 suppresses tumor progression in melanoma by downregulating epithelial-mesenchymal transition markers and reducing invasion in the tumor microenvironment.^[65] These dual functions underscore CD63's regulatory versatility in pathway feedback dynamics.

References

[1]
967 - Gene ResultCD63 CD63 molecule [ (human)] - NCBI
Sep 9, 2025 · CD63 serves as an adaptor protein that links its interaction partners to the endocytic machinery of the cell.
[2]
Prognostic Value of CD63 Expression in Solid Tumors - NIH
Sep 3, 2020 · The tetraspanin protein CD63 has been described as a key factor in extracellular vesicle production and endosomal cargo sorting, and there have ...
[3]
Sequential deletion of CD63 identifies topologically distinct scaffolds ...
Jun 11, 2020 · CD63 is a hallmark protein of natural exosomes that is highly enriched on the external surface of the membrane. We have previously described ...
[4]
Tetraspanin CD63 is a regulator of HIV-1 replication - PMC - NIH
CD63 is a tetraspanin transmembrane protein, which has been shown to play an essential role during HIV-1 replication in macrophages. In this study, we further ...
[5]
The protein CD63 is in platelet dense granules, is deficient in a ...
This is the first report of a protein present in platelet dense granules, lysosomes, and melanocytes, but deficient in a patient with Hermansky-Pudlak syndrome.
[6]
The gene for lysosomal protein CD63 is normal in patients ... - PubMed
Hermansky-Pudlak syndrome (HPS) is one of the few genetic disorders associated with severe pulmonary fibrosis. Fifty percent of affected patients die as a ...
[7]
Genomic structure of the ME491/CD63 antigen gene and ... - PubMed
Genomic structure of the ME491/CD63 antigen gene and promoter activity of the 5'-flanking regulatory sequences were studied. The antigen gene consists of ...
[8]
CD63 is regulated by iron via the IRE-IRP system and is important ...
Oct 21, 2021 · CD63, a tetraspanin protein and constituent of extracellular vesicles, is induced by iron and in turn that this increases the secretion by various cells.
[9]
Tissue expression of CD63 - Summary - The Human Protein Atlas
The value ranges from 0 and 1, where 0 indicates identical expression across all cells/tissue types, while 1 indicates expression in a single cell/tissue type.
[10]
CD63 protein expression summary - The Human Protein Atlas
Genes can have enriched specificity in different cell types in one or several tissues, or be enriched in a core cell type that appears in many different tissues ...
[11]
The tetraspanin CD63 enhances the internalization of the H ... - PNAS
The tetraspanin CD63 resides in late endosomes, lysosomes, secretory vesicles, and at the plasma membrane, and it moves among these compartments.
[12]
Trafficking and function of the tetraspanin CD63 - ScienceDirect.com
May 15, 2009 · In addition to its presence in TEMs, CD63 is also abundantly present in late endosomes and lysosomes. CD63 at the cell surface is endocytosed ...
[13]
Characterization of tetraspanins CD9, CD53, CD63, and CD81 in ...
Apr 9, 2013 · This study is the first to comprehensively characterize tetraspanin expression on monocyte subsets and macrophages in health and during HIV-1 infection.Missing: basophils | Show results with:basophils<|separator|>
[14]
Flow cytometry based platelet activation markers and state of ...
Jun 16, 2022 · CD63 is platelet dense granule and lysosomal membrane protein. It is another marker whose surface expression is increased following activation.
[15]
Changes of Platelet Surface Antigens in Patients Suffering from ...
Changes in CD63 and CD62P expression indicates platelet activation. Because ... Understanding the molecular mechanism of platelet regulation in inflammation ...
[16]
The tetraspanin CD63 regulates ESCRT-independent and ... - NIH
CD63 localizes to melanosomes and to PMEL-positive MVEs. We first tested whether CD63 localizes to melanosomal compartments in pigmented MNT-1 melanoma cells, a ...
[17]
CD63 antigen. A novel lysosomal membrane glycoprotein, cloned ...
The single long open reading frame of 238 amino acids contained four putative transmembrane regions and three N-glycosylation sites. The CD63 gene was expressed ...
[18]
Tetraspanins Function as Regulators of Cellular Signaling - Frontiers
Tetraspanins have four transmembrane domains (TM1-TM4), which create one small (EC1) and one large (EC2) extracellular loop as well as a short inner loop. The N ...
[19]
Tetraspanins: structure, dynamics, and principles of partner protein ...
Tetraspanins are small, ranging from 22 to 39 kDa in mass, and they contain four main functional domains—the transmembrane region, two distinct extracellular ...
[20]
The Tetraspanin CD63/lamp3 Cycles between Endocytic and ...
Oct 13, 2017 · CD63 is a well-established component of the late endosomal and lysosomal membranes, also known as lysosome-associated membrane protein 3 (lamp3) ...
[21]
[PDF] CD63 (NK1/C3): sc-59286 - Santa Cruz Biotechnology
The tetraspanin CD63 (also known as LAMP-3, melanoma ... Molecular Weight of CD63 core protein: 26 kDa. Molecular Weight of glycosylated CD63: 30-60 kDa.
[22]
CD63 General Information - Sino Biological
The sequence of the cDNA indicates that the antigen has 237 amino acids (molecular mass, 25,475 Da) with 4 transmembrane regions and 3 putative N-glycosylation ...
[23]
Crystal structure of a full-length human tetraspanin reveals a ...
Here we report the crystal structure of a full-length tetraspanin, human CD81. The transmembrane segments of CD81 pack as two largely separated pairs of ...
[24]
CD63 antigen - Homo sapiens (Human) | UniProtKB | UniProt
Functions as a cell surface receptor for TIMP1 and plays a role in the activation of cellular signaling cascades.
[25]
RPN2-mediated glycosylation of tetraspanin CD63 regulates breast ...
May 31, 2014 · In this study, we demonstrate that cancer malignancy associated with the glycosylation of CD63 is regulated by RPN2.
[26]
https://doi.org/10.1091/mbc.01-05-0275
[27]
RNF149 negatively regulates LPS/TLR4 signal transduction by ... - NIH
Jul 11, 2024 · RNF149 plays a negative regulatory role in LPS/TLR4 signal transduction by mediating ubiquitination-induced CD63 degradation.
[28]
https://doi.org/10.1016/j.devcel.2011.08.019
[29]
Timp1 interacts with beta-1 integrin and CD63 along melanoma ...
Mar 25, 2013 · Inhibition of CD63 expression was able to effectively reduce TIMP1 binding on the cell surface and its co-localization with β1-integrins.
[30]
Mapping of tetraspanin-enriched microdomains that can function as ...
Here, we reveal the presence of tetraspanin-enriched microdomains (TEMs) containing the tetraspanins CD9, CD63, CD81, and CD82 at the plasma membrane.
[31]
Palmitoylation supports the association of tetraspanin CD63 with ...
These results demonstrate that palmitoylation is required for platelet tetraspanin-tetraspanin and tetraspanin-integrin interaction and for complete platelet ...Missing: cysteines web
[32]
The tissue inhibitor of metalloproteinases 1 increases the ...
Our findings are consistent with previous results showing that CD63 recruits PI3K, MAPK, and Akt, igniting signaling pathways involved in the proliferative and ...
[33]
CD63 is regulated by iron via the IRE-IRP system and is important ...
Oct 21, 2021 · 3 CD63 is localized to intraluminal vesicles of late endosomes and multivesicular bodies and is enriched in EVs.4, 5 Intriguingly, CD63 ...
[34]
https://www.sciencedirect.com/science/article/pii/S0301472X15005159
[35]
Trafficking and function of the tetraspanin CD63
### Summary of CD63 Trafficking and Function
[36]
Tetraspanins interweave EV secretion, endosomal network ...
New valuable insights regarding tetraspanin molecular structure have been possible thanks to the recently resolved crystal structures of CD81 (Zimmerman et al., ...Missing: homology | Show results with:homology
[37]
https://www.sciencedirect.com/science/article/pii/S0014482708003935
[38]
https://www.sciencedirect.com/science/article/pii/S0171933522000322
[39]
Real-Life Utility of Basophil Activation Test in the Diagnosis of ... - PMC
Nov 28, 2023 · The basophil activation test (BAT) is a flow cytometry laboratory technique that assesses the level of activation indicators expressed on the surface of ...
[40]
Platelet activation markers and the primary antiphospholipid ...
Median platelet CD63 expression and plasma soluble P-selectin levels were significantly increased in PAPS patients compared to a group of controls; there was no ...
[41]
MEASUREMENT OF PLATELET ACTIVATION MARKERS CD62P ...
May 24, 2024 · Objective: This study aimed to assess the efficacy of measuring platelet surface activation markers, CD62P and CD63, using flow cytometry to ...
[42]
Quantification of plasma exosome is a potential prognostic marker ...
Sep 5, 2016 · We analyzed the tumor-derived exosome behavior and assessed the quantification of exosomes in patient plasma as a biomarker for esophageal squamous cell ...
[43]
614075 - HERMANSKY-PUDLAK SYNDROME 6; HPS6 - OMIM
... Hermansky-Pudlak syndrome. All mutations except 1 resulted in a truncated protein. The phenotype was characterized by early-onset nystagmus, oculocutaneous ...Missing: CD63 | Show results with:CD63<|control11|><|separator|>
[44]
Hermansky-Pudlak Syndrome: Identification of Novel Variants in the ...
Biallelic Mutations in AP3D1 Cause Hermansky-Pudlak Syndrome Type 10 Associated with Immunodeficiency and Seizure Disorder. Eur. J. Med. Genet. 62 (11), 103583.
[45]
Aberrant TIMP-1 overexpression in tumor-associated fibroblasts ...
We analyzed the expression of TIMP-1 and its cell surface receptor CD63 in two major lung cancer subtypes: lung adenocarcinoma (ADC) and squamous cell carcinoma ...
[46]
Exploring CD63 as a target in the diagnostics and treatment of cancer
Jun 21, 2024 · The tetraspanin family member CD63, also referred to as LAMP3, is widely expressed on the membrane surface of macrophages and lymphocytes.<|control11|><|separator|>
[47]
Abstract 5091: TIMP-1 in tumor-associated fibroblasts drives tumor ...
Aug 15, 2020 · Abstract 5091: TIMP-1 in tumor-associated fibroblasts drives tumor progression in lung adenocarcinoma through CD63 interaction Available.Missing: metastasis | Show results with:metastasis
[48]
CD63 + tumor-associated macrophages drive the progression of ...
CD63 + tumor-associated macrophages drive the progression of hepatocellular carcinoma through the induction of epithelial-mesenchymal transition ...Missing: overexpression | Show results with:overexpression
[49]
Two patients with Hermansky Pudlak syndrome type 2 and novel ...
Cytotoxic T-lymphocyte (CTL) clones from both study subjects showed increased cell-surface expression of CD63 and reduced cytotoxicity. Platelets showed ...<|control11|><|separator|>
[50]
Does SARS-CoV-2 infect platelets? - Frontiers
Apr 22, 2024 · Consistently, platelet activation is evident by increased expression of P-selectin CD40 and CD63 on the surface of platelets from patients with ...
[51]
Circulating Activated Platelets in Children With Long COVID - NIH
Jul 15, 2024 · Noteworthy, the present data agree with the increased p-selectin and CD63 expression on circulating platelets of adults 1 year after COVID-19.Missing: hyperactivation | Show results with:hyperactivation
[52]
Minimal information for studies of extracellular vesicles 2018 ...
In this updated version, MISEV2018, reference to exosomes and the proteins expected or not in them (the previously called “negative controls” of “exosome” ...
[53]
Exosomes: Small Vesicles with Important Roles in the Development ...
This review will focus on exosomes in EVs for the occurrence and progression of breast cancer, as biomarkers to predict breast cancer, and exosome-based novel ...
[54]
Identification of CD63 as a tissue inhibitor of metalloproteinase‐1 ...
Taken together, the present study identified CD63 as a cell surface binding partner for TIMP‐1, regulating cell survival and polarization via TIMP‐1 modulation ...
[55]
Timp1 interacts with beta-1 integrin and CD63 along melanoma ...
Mar 25, 2013 · Inhibition of CD63 expression was able to effectively reduce TIMP1 binding on the cell surface and its co-localization with β1-integrins.Missing: LAMP ESCRT
[56]
Characteristics of TIMP1, CD63, and β1-Integrin and the Functional ...
In this study, the TIMP1/CD63/β1-integrin complex induced the FAK-mediated signaling pathway, triggering hypermotility and hypermigration [88]. A recent study ...
[57]
Characterization of Integrin–Tetraspanin Adhesion Complexes
In addition to CD63 and CD81, these cells abundantly express three other TM4SF proteins including CD9, CD82, and CD151/PETA-3, and, therefore, represent a good ...
[58]
Determination of protein regions responsible for ... - PubMed
Dec 15, 2007 · Amelogenin interacts with the transmembrane proteins CD63 and LAMP (lysosome-associated membrane protein) 1, which are involved in endocytosis.<|control11|><|separator|>
[59]
Epstein-Barr Virus LMP1 Modulates the CD63 Interactome - MDPI
Our results showed that LMP1 alters the CD63 interactome, shifting the network of protein enrichment from protein localization and vesicle-mediated ...
[60]
Epstein-Barr Virus LMP1 Modulates the CD63 Interactome - PMC
The pull-downs confirmed CD63 interaction with Rab GTPases and other proteins involved in the endolysosomal pathway including Rab8A and Rab21A, clathrin ...
[61]
Endocytosis blocks the vesicular secretion of exosome marker proteins
Finally, we show that high-level expression of CD63, which binds directly to the clathrin adaptor AP-2 subunit mu2, inhibits endocytosis, induces the plasma ...
[62]
Characteristics of TIMP1, CD63, and β1-Integrin and the Functional ...
[28]. Tetraspanins are characterized by highly conserved sequences in their four transmembrane domains and by the presence of the CCG motif within the large ...<|control11|><|separator|>
[63]
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates ...
Jul 7, 2023 · It has been reported that tetraspanins, including CD63, promote proliferation, migration and chemoresistance via activating PI3K/AKT signaling [82], and that ...
[64]
The tetraspanin CD63 is required for efficient IgE-mediated mast cell ...
While antibodies against the tetraspanins CD63 and CD81 inhibit FcεRI-induced mast cell degranulation, the intrinsic role of these molecules in FcεRI-induced ...
[65]
Revisiting the Role of CD63 as Pro‐Tumorigenic or Anti ...
May 4, 2023 · CD63 expression possesses both pro- and anti-tumorigenic characteristics. Alteration in glycans of CD63 shows an impact on cancer cell ...